Overview
I am interested clinically in all abdominal organ transplants (kidney, liver, pancreas and intestine). I am specifically interested in intestine transplantation and improving intestine graft preservation and long-term graft function and patient survival. In addition, I am interested in monitoring of patients to improve our ability to determine the etiology of graft dysfunction when there are complex interacting issues such as infection and rejection as well as examining better immunosuppressive regimens to maintain excellent graft function. We have numerous research studies and trial to improve our knowledge in these areas and thereby contribute to improved patient outcomes!
Current Appointments & Affiliations
Professor of Surgery
·
2011 - Present
Surgery, Abdominal Transplant Surgery,
Surgery
Division Chief of Abdominal Transplant in the Department of Surgery
·
2011 - Present
Surgery,
Clinical Science Departments
Professor in Pediatrics
·
2009 - Present
Pediatrics,
Clinical Science Departments
Recent Publications
Transforming the logistics of liver transplantation with normothermic machine perfusion: Clinical impact versus cost.
Journal Article Liver Transpl · June 1, 2025 Normothermic machine perfusion (NMP) facilitates the utilization of marginal liver allografts. It remains unknown whether clinical benefits offset additional costs in the real-world setting. We performed a comparison of outcomes and hospitalization costs f ... Full text Link to item CiteSystem Interventions to Achieve Early and Equitable Kidney Transplants (STEPS): Protocol for STEPS, a randomized comparative effectiveness clinical trial.
Journal Article Contemp Clin Trials · June 2025 The System Interventions to Achieve Early and Equitable Kidney Transplants Study (STEPS) is an ongoing pragmatic clinical trial investigating the effectiveness of an equitable and patient-centered approach to kidney care on equitable access to early kidney ... Full text Link to item CiteAdvances in the treatment of hepatocellular carcinoma: An overview of the current and evolving therapeutic landscape for clinicians.
Journal Article CA Cancer J Clin · May 20, 2025 Hepatocellular carcinoma (HCC) is the sixth most common malignancy and the third leading cause of cancer-related death worldwide. Contemporary advances in systemic and locoregional therapies have led to changes in peer-reviewed guidelines regarding systemi ... Full text Link to item CiteRecent Grants
STARS Extension Study
Clinical TrialPrincipal Investigator · Awarded by VectivBio AG · 2022 - 2032FP-Assessment of Biomarker Guided CNI Substitution in Kidney Transplantation
Clinical TrialPrincipal Investigator · Awarded by Cedars Sinai Medical Center · 2023 - 2029Assessment of Biomarker Guided CNI Substitution in Kidney Transplantation
Clinical TrialPrincipal Investigator · Awarded by Cedars Sinai Medical Center · 2023 - 2029View All Grants
Education, Training & Certifications
Wright State University ·
1994
M.D.